Vitamin D and calcium are essential to bone biology, yet routinely giving more of them does not automatically prevent fractures, and the distinction is between nutrient adequacy and supplementation as a preventive medicine. If you have severe vitamin D deficiency or an inadequate calcium intake, you may need correction. If you are a generally healthy adult who already has enough, extra tablets may not buy you any fracture protection.
The 2026 BMJ systematic review included 69 randomized trials and 153,902 adults. Calcium alone, vitamin D alone, and their combination produced little to no clinically meaningful reduction in most fracture and fall outcomes. The VITAL fracture trial reached a similar conclusion for vitamin D in generally healthy midlife and older adults. These findings narrow routine use without erasing diagnosis-specific care.
Why the biological argument sounds convincing#
Calcium is the main mineral in bone. Vitamin D supports calcium absorption and participates in mineral metabolism. Severe vitamin D deficiency can cause osteomalacia in adults, producing weak mineralization, bone pain, weakness, and fractures. Severe calcium deficiency can disrupt bone and other physiology.
From those facts, it is tempting to conclude that supplements prevent fractures in everyone. That inference skips the shape of a nutrient response. Correcting inadequacy can help, while adding more after requirements are met may produce little benefit and more harm. Randomized trials test the population question: they compare a defined supplement strategy with placebo or control and count fractures or falls, rather than assuming a laboratory or bone-density change will translate into fewer clinical events.
What the 2026 systematic review added#
The BMJ review searched through February 2025 and pooled 69 randomized trials with 153,902 adults; it evaluated calcium, vitamin D, and combined supplementation against placebo or no treatment for fractures and falls.
For any fracture, calcium alone had a pooled risk ratio of 0.91 with a confidence interval from 0.81 to 1.01. Vitamin D alone had a risk ratio of 1.00, with a 95 percent interval from 0.95 to 1.06. Combined calcium and vitamin D had a ratio of 0.91, with an interval from 0.84 to 0.99.
The combined result is statistically below 1, but the review judged the absolute effect small and below its threshold for a clinically meaningful benefit, because a statistically detectable difference can still be too small to justify routine treatment across a broad population.
Population mix limits simple conclusions#
Most trial participants lived in the community, and many were not selected for high fracture or fall risk. Few trials focused on people with severe deficiency. Institutionalized older adults can have lower dietary intake, less sunlight, frailty, and different baseline risk.
The average result therefore answers routine supplementation in broad adult populations better than it answers targeted correction in a high-risk subgroup. A null overall effect does not prove no one benefits. A favorable subgroup found after many comparisons also does not prove benefit without credible interaction evidence. The review did examine subgroups. But varying definitions, doses, and co-interventions limit how certain anyone can be about the exact exceptions. So do adherence and risk of bias.
VITAL tested vitamin D in a large population#
The VITAL ancillary fracture study included 25,871 US adults, men at least 50 and women at least 55, randomized to vitamin D3 at 2,000 international units daily or placebo in a factorial trial. Participants were not recruited for vitamin D deficiency, low bone mass, or osteoporosis.
During median follow-up of about five years, vitamin D did not significantly reduce total fractures, nonvertebral fractures, or hip fractures, and the result was similar across several prespecified subgroups, including baseline vitamin D level. VITAL is powerful for the question it asked: adding this dose to generally healthy adults. It is not a treatment trial for osteomalacia and does not establish that a person with malabsorption should remain untreated.
The older USPSTF recommendation was already cautious#
The 2018 USPSTF recommended against daily supplementation with 400 international units or less of vitamin D and 1,000 milligrams or less of calcium for primary fracture prevention in community-dwelling postmenopausal women. The recommendation was based partly on the Women's Health Initiative, which did not show fracture benefit and found more kidney stones.
For higher doses in postmenopausal women and for men and premenopausal women, evidence was insufficient at the time. The statement applies to asymptomatic community-dwelling adults without prior osteoporotic fracture, osteoporosis, or vitamin D deficiency. The 2026 review broadens and updates that evidence, and those boundaries still decide whether any of it describes you.
Calcium intake and calcium pills are not identical#
Dietary calcium arrives with protein and other nutrients and is spread across meals. Supplements deliver a concentrated amount and can cause constipation, bloating, and kidney stones. Absorption varies by salt form, meal timing, acid suppression, and dose.
Your total intake includes food, fortified products, and supplements, so adding a full supplement before anyone has estimated what you already eat can overshoot the need. Someone avoiding dairy without another calcium source may have inadequate intake.
Cardiovascular safety of calcium supplements has been debated. Trials and meta-analyses have produced mixed findings, partly because events were not always primary outcomes. The uncertainty supports using supplements to fill a demonstrated gap rather than assuming universal benefit.
Vitamin D dose and schedule matter#
Vitamin D can be given daily, weekly, monthly, or in large intermittent boluses. These schedules are not biologically or clinically interchangeable. Some high-dose intermittent regimens have increased falls or fractures in trials.
The 2024 Endocrine Society guideline suggests against routine doses above the dietary reference intake for generally healthy adults younger than 75 when the goal is preventing disease. It identifies selected life stages and groups where empiric supplementation may be considered, while emphasizing uncertainty about optimal dose and blood targets. Taking several products can create accidental duplication. Your multivitamin, a calcium combination, fortified foods, and a standalone vitamin D all count toward the same total.
High levels can cause real toxicity#
Vitamin D toxicity usually results from excessive supplement intake rather than ordinary food or sunlight. It can raise blood calcium, causing nausea, weakness, and confusion. It can cause thirst, frequent urination, and kidney stones. It can cause kidney injury and abnormal heart rhythms.
Calcium supplements can cause gastrointestinal symptoms and increase stone risk in susceptible people. Kidney disease, sarcoidosis and other granulomatous disorders, hyperparathyroidism, and certain medicines can change calcium and vitamin D handling. The label “natural” does not remove pharmacology. More is not a safety strategy.
Osteoporosis treatment is a different question#
Osteoporosis is diagnosed through fracture history, bone-density criteria, or risk assessment depending on context. Effective osteoporosis medicines reduce vertebral, hip, or other fractures in defined high-risk groups. Trials generally ensure reasonable calcium and vitamin D status so mineral deficiency does not complicate treatment.
This supportive requirement should not be misrepresented as proof that supplements alone treat osteoporosis. A person at high fracture risk may need bisphosphonate, denosumab, anabolic therapy, or another agent. The choice rests on kidney function, fracture pattern, and prior therapy. It also rests on cancer history and preferences. Stopping some bone medicines without a transition plan can increase fracture risk. Supplement decisions should not distract from treatment continuity.
Long-term care may differ from community living#
Older adults in residential care can have low intake, limited mobility, frailty, and greater deficiency risk. Some earlier trials in institutional settings suggested hip-fracture benefit from combined calcium and vitamin D, particularly where baseline intake was low.
The 2026 review included institutional and community studies, but most participants were community dwelling. A facility-level supplementation protocol should consider diet, swallowing, and kidney function. It should consider medicines, falls, and current evidence rather than simply importing a community recommendation. This is an applicability question, not a loophole to treat every older adult the same way.
Fractures are not caused by one nutrient#
Bone strength reflects bone density, architecture, and turnover. It reflects hormones, genetics, and age. It reflects medicines, disease, activity, nutrition, and prior fractures. Whether a person falls and how they land matters too.
Glucocorticoids, aromatase inhibitors, androgen-deprivation therapy, antiseizure medicines, and other treatments can alter bone. Hyperthyroidism, hyperparathyroidism, and celiac disease are among the secondary causes considered when the pattern fits. So are kidney disease, hypogonadism, and multiple myeloma. Treating a low vitamin D number without evaluating a fragility fracture can miss the more important diagnosis.
Strength and balance address two pathways#
Progressive resistance exercise supports muscle and bone loading. Balance training and functional practice reduce falls in selected older adults. The program should match baseline ability and account for vertebral fractures, joint disease, neuropathy, vision, and cardiovascular symptoms.
Walking supports general health but may not provide enough resistance by itself to maximize bone strength. High-impact exercise may be unsuitable for severe osteoporosis or recent fracture without professional adaptation. And the other half of fall prevention never happens in a gym: the rug at the top of your stairs, your footwear, your vision, orthostatic blood pressure, sedating medicines, alcohol, and whether you have the walking aid you actually need.
Food adequacy still matters#
The absence of routine supplement benefit does not support a calcium-free or nutritionally poor diet. Dairy products, fortified alternatives, calcium-set tofu, canned fish with bones, and some greens contribute calcium. Fatty fish, fortified foods, and supplements contribute vitamin D.
Protein and total energy are important for bone and muscle, particularly in frailty. A restrictive diet that adds two pills while lacking protein and calories is not comprehensive fracture prevention. Dietary needs vary with age, pregnancy, kidney disease, absorption, and medicines. A clinician or dietitian can estimate intake and identify a gap without prescribing a universal menu.
Ask which evidence population you resemble#
Before you take a supplement trial personally, check whether its participants had deficiency, osteoporosis, or prior fracture. Check whether they had institutional residence, kidney disease, or malabsorption. Find the baseline intake and whether calcium was coadministered, and note the dose, the schedule, the adherence, and how a fracture was defined.
Then examine absolute event rates and harms. A relative reduction of a few percent can represent almost no absolute benefit in a low-risk group. A high-risk group can have a different balance even with the same relative effect. The responsible conclusion is not “vitamins never work.” It is that routine supplementation for fracture prevention has little value in most unselected community adults.
Build fracture prevention around risk#
Review your prior fractures, bone density when indicated, and age. Review family history, falls, and medicines. Review smoking, alcohol, nutrition, kidney function, and secondary causes. Correct a genuine nutrient inadequacy. Use bone-directed medicine when your risk warrants it, and add strength, balance, vision, and home-safety interventions.
If you do take supplements, be clear about your total intake, your kidney-stone history, interactions, and monitoring. Avoid duplicate products and high intermittent regimens without an evidence-based indication.
Calcium and vitamin D remain necessary nutrients. Their necessity does not make tablets a universal anti-fracture treatment.
References#
- BMJ 2026 systematic review of calcium, vitamin D, fractures, and falls
- VITAL randomized trial of vitamin D and fractures
- USPSTF recommendation on supplements for primary fracture prevention
- Endocrine Society 2024 vitamin D guideline
- NIH vitamin D fact sheet
- NIH calcium fact sheet
For your own health, talk with your clinician.*
Questions and answers
Should every older adult take vitamin D and calcium to prevent fractures?
No. Large trials show little or no meaningful routine benefit for most community adults. Diet, deficiency, osteoporosis, medicines, kidney function, residence, and fracture risk determine whether supplementation has another indication.
Does this mean calcium and vitamin D are unimportant for bone?
No. Both are required nutrients, but correcting inadequate intake or deficiency is different from adding supplements to an already sufficient population.
Did the VITAL trial include people with osteoporosis?
It enrolled generally healthy midlife and older adults and did not select participants for osteoporosis, severe deficiency, or high fracture risk. Its null result should be applied to that population.
Can supplements cause harm?
Yes. Calcium can cause constipation and kidney stones. Excess vitamin D can cause high blood calcium, kidney injury, confusion, weakness, and abnormal rhythms. Risk depends on total intake and health.
What prevents fractures besides supplements?
Risk-based osteoporosis medicine, resistance and balance activity, fall prevention, adequate protein and minerals, vision care, medicine review, and treatment of secondary causes can be more important.